160 related articles for article (PubMed ID: 22871636)
1. Correlation of coreceptor usage and disease progression.
Verhofstede C; Nijhuis M; Vandekerckhove L
Curr Opin HIV AIDS; 2012 Sep; 7(5):432-9. PubMed ID: 22871636
[TBL] [Abstract][Full Text] [Related]
2. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
3. Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.
Arif MS; Hunter J; Léda AR; Zukurov JPL; Samer S; Camargo M; Galinskas J; Kallás EG; Komninakis SV; Janini LM; Sucupira MC; Diaz RS
J Virol; 2017 Oct; 91(19):. PubMed ID: 28659473
[TBL] [Abstract][Full Text] [Related]
4. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
5. Stable coreceptor usage of HIV in patients with ongoing treatment failure on HAART.
Lehmann C; Däumer M; Boussaad I; Sing T; Beerenwinkel N; Lengauer T; Schmeisser N; Wyen C; Fätkenheuer G; Kaiser R
J Clin Virol; 2006 Dec; 37(4):300-4. PubMed ID: 17005445
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection.
Moyle GJ; Wildfire A; Mandalia S; Mayer H; Goodrich J; Whitcomb J; Gazzard BG
J Infect Dis; 2005 Mar; 191(6):866-72. PubMed ID: 15717260
[TBL] [Abstract][Full Text] [Related]
7. Emergence, dominance, and possible decline of CXCR4 chemokine receptor usage during the course of HIV infection.
Meehan CJ; Hedge JA; Robertson DL; McCormack GP; Travers SA
J Med Virol; 2010 Dec; 82(12):2004-12. PubMed ID: 20981786
[TBL] [Abstract][Full Text] [Related]
8. Predominance of CXCR4 tropism in HIV-1 CRF14_BG strains from newly diagnosed infections.
Pérez-Álvarez L; Delgado E; Vega Y; Montero V; Cuevas T; Fernández-García A; García-Riart B; Pérez-Castro S; Rodríguez-Real R; López-Álvarez MJ; Fernández-Rodríguez R; Lezaun MJ; Ordóñez P; Ramos C; Bereciartua E; Calleja S; Sánchez-García AM; Thomson MM
J Antimicrob Chemother; 2014 Jan; 69(1):246-53. PubMed ID: 23900735
[TBL] [Abstract][Full Text] [Related]
9. Use of (alternative) coreceptors for HIV entry.
Pollakis G; Paxton WA
Curr Opin HIV AIDS; 2012 Sep; 7(5):440-9. PubMed ID: 22842622
[TBL] [Abstract][Full Text] [Related]
10. Comparison of in vivo and in vitro evolution of CCR5 to CXCR4 coreceptor use of primary human immunodeficiency virus type 1 variants.
Edo-Matas D; van Dort KA; Setiawan LC; Schuitemaker H; Kootstra NA
Virology; 2011 Apr; 412(2):269-77. PubMed ID: 21295814
[TBL] [Abstract][Full Text] [Related]
11. High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch.
Mild M; Gray RR; Kvist A; Lemey P; Goodenow MM; Fenyö EM; Albert J; Salemi M; Esbjörnsson J; Medstrand P
Infect Genet Evol; 2013 Oct; 19():369-77. PubMed ID: 23672855
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 co-receptor usage based on V3 loop sequence analysis: preferential suppression of CXCR4 virus post HAART?
Jiao Y; Wang P; Zhang H; Zhang T; Zhang Y; Zhu H; Wu H
Immunol Invest; 2011; 40(6):597-613. PubMed ID: 21513481
[TBL] [Abstract][Full Text] [Related]
13. Coreceptor usage by HIV-1 and HIV-2 primary isolates: the relevance of CCR8 chemokine receptor as an alternative coreceptor.
Calado M; Matoso P; Santos-Costa Q; Espirito-Santo M; Machado J; Rosado L; Antunes F; Mansinho K; Lopes MM; Maltez F; Santos-Ferreira MO; Azevedo-Pereira JM
Virology; 2010 Dec; 408(2):174-82. PubMed ID: 20947116
[TBL] [Abstract][Full Text] [Related]
14. HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use.
Karlsson I; Antonsson L; Shi Y; Karlsson A; Albert J; Leitner T; Olde B; Owman C; Fenyö EM
AIDS; 2003 Dec; 17(18):2561-9. PubMed ID: 14685050
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
Spudich SS; Huang W; Nilsson AC; Petropoulos CJ; Liegler TJ; Whitcomb JM; Price RW
J Infect Dis; 2005 Mar; 191(6):890-8. PubMed ID: 15717264
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of HIV coreceptor tropism.
Hoffmann C
Eur J Med Res; 2007 Oct; 12(9):385-90. PubMed ID: 17933718
[TBL] [Abstract][Full Text] [Related]
17. Broad spectrum of coreceptor usage and rapid disease progression in HIV-1-infected individuals from Central African Republic.
Bégaud E; Feindirongai G; Versmisse P; Ipero J; Léal J; Germani Y; Morvan J; Fleury H; Müller-Trutwin M; Barré-Sinoussi F; Pancino G
AIDS Res Hum Retroviruses; 2003 Jul; 19(7):551-60. PubMed ID: 12908932
[TBL] [Abstract][Full Text] [Related]
18. HIV type 1 tropism and inhibitors of viral entry: clinical implications.
Weber J; Piontkivska H; Quiñones-Mateu ME
AIDS Rev; 2006; 8(2):60-77. PubMed ID: 16848274
[TBL] [Abstract][Full Text] [Related]
19. Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch.
Mild M; Esbjörnsson J; Fenyö EM; Medstrand P
J Virol; 2007 Apr; 81(7):3369-76. PubMed ID: 17251288
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.
Garrido C; Roulet V; Chueca N; Poveda E; Aguilera A; Skrabal K; Zahonero N; Carlos S; García F; Faudon JL; Soriano V; de Mendoza C
J Clin Microbiol; 2008 Mar; 46(3):887-91. PubMed ID: 18199789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
